Alnylam Pharmaceuticals, Inc.

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

23,220

Value ($000)

9,233

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,233	0.0%	23,220	12/31/2025
2025 Q3	11/13/2025	8,545	0.0%	18,739	9/30/2025
2025 Q2	8/14/2025	6,675	0.0%	20,471	6/30/2025
2025 Q1	5/14/2025	6,660	0.0%	24,666	3/31/2025
2024 Q4	2/18/2025	5,784	0.0%	24,582	12/31/2024
2024 Q3	11/14/2024	5,805	0.0%	21,108	9/30/2024
2024 Q2	8/14/2024	5,885	0.0%	24,217	6/30/2024
2024 Q1	5/15/2024	2,239	0.0%	14,983	3/31/2024
2023 Q4	2/14/2024	2,753	0.0%	14,384	12/31/2023
2023 Q3	11/14/2023	2,005	0.0%	11,321	9/30/2023
2023 Q2	8/11/2023	2,123	0.0%	11,177	6/30/2023
2023 Q1	5/12/2023	2,195	0.0%	10,958	3/31/2023
2022 Q4	2/13/2023	2,527	0.0%	10,634	12/31/2022
2022 Q3	11/10/2022	2,384	0.0%	11,908	9/30/2022
2022 Q2	8/12/2022	2,031	0.0%	13,925	6/30/2022
2022 Q1	5/12/2022	3,015	0.0%	18,462	3/31/2022
2021 Q4	2/11/2022	3,552	0.0%	20,948	12/31/2021
2021 Q3	11/12/2021	4,089	0.0%	21,659	9/30/2021
2021 Q2	9/29/2021	3,672	0.0%	21,662	6/30/2021
2021 Q1	4/30/2021	2,686	0.0%	19,023	3/31/2021
2020 Q4	2/2/2021	2,538	0.0%	19,531	12/31/2020
2020 Q3	11/10/2020	2,899	0.0%	19,913	9/30/2020
2020 Q2	8/12/2020	2,672	0.0%	18,041	6/30/2020
2020 Q1	5/13/2020	1,328	0.0%	12,197	3/31/2020
2019 Q4	2/12/2020	3,018	0.0%	26,204	12/31/2019